Department of Otorhinolaryngology, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huaian, China.
Department of Radiology & Medical Imaging, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huaian, China.
J Int Med Res. 2021 Apr;49(4):300060521995273. doi: 10.1177/0300060521995273.
To examine the clinical effects of revision endoscopic frontal sinus surgery (RESS) through modified agger nasi (MAN)-middle turbinate resection on refractory chronic rhinosinusitis (CRS).
We reviewed 156 patients who were treated for refractory CRS from February 2012 to August 2014. These patients had been diagnosed with refractory CRS by computed tomography and endoscopy and had received several surgical and medical treatments in the past, but their condition had not been cured. They were divided into the observation group (RESS through MAN-middle turbinate resection, n = 78) and the control group (endoscopic sinus surgery, n = 78). Complete or partial control of the patient's symptoms and signs suggested that the treatment was effective, and no improvement in the symptoms and signs indicated that the treatment was ineffective.
The 6-month treatment efficacy rate was significantly higher in the observation group (91.03%) than in the control group (71.79%). The observation group had a significantly lower complication rate (7.69%) and recurrence rate (3.85%) than the control group (17.95% and 12.82%, respectively).
RESS through MAN-middle turbinate resection together with adequate perioperative preparation has a significant effect on the outcome of refractory CRS and is worthy of clinical promotion.
探讨改良额隐窝-中鼻甲径路内镜鼻窦修正手术（RESS）治疗难治性慢性鼻-鼻窦炎（CRS）的临床效果。
回顾性分析 2012 年 2 月至 2014 年 8 月收治的 156 例难治性 CRS 患者的临床资料，所有患者均经 CT 和鼻内镜检查确诊为难治性 CRS，既往均接受过多次手术和药物治疗，但症状无缓解。将患者分为观察组（改良额隐窝-中鼻甲径路内镜鼻窦修正手术，n=78）和对照组（鼻内镜鼻窦手术，n=78）。患者症状和体征完全或部分缓解为治疗有效，症状和体征无改善为治疗无效。
观察组患者治疗 6 个月的有效率（91.03%）明显高于对照组（71.79%），并发症发生率（7.69%）和复发率（3.85%）明显低于对照组（17.95%、12.82%）。
改良额隐窝-中鼻甲径路内镜鼻窦修正手术治疗难治性 CRS 效果显著，值得临床推广应用。
